Related Experiment Video
Updated: May 14, 2026
Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
Published on: January 31, 2020
Considerations for Designing a Microbial Challenge Study: Poster Presented at PDA Microbiology Conference 2025
Randy Wolford1, Samantha Chang2
1Eurofins Lancaster Laboratories randy.wolford@bpt.eurofinsus.com.
Abstract:
As the pharmaceutical industry continually evolves, so do regulatory requirements for biological products and establishing in-use hold times for products in a clinical setting. Although adapted from USP Chapter <51>, microbial challenge studies are non-compendial studies that evaluate the microbial growth potential of a product spiked with a low level of microorganisms to simulate inadvertent contamination during dose preparation.Microbial challenge studies provide information on how long drug products can be held before patient safety is at risk, the effectiveness of any preservatives and/or preservative ingredients, optimum storage conditions, and ultimately, if the drug product formulation can withstand low level contamination. If microorganisms can grow in the product during the holding period, then the intended hold time, product formulation, or storage conditions should be reevaluated.When designing a microbial challenge study, multiple factors should be considered. This includes, but is not limited to, the inherent characteristics of the drug product formulation, the storage condition(s) of the drug product, target organisms (i.e., organisms prevalent in a hospital setting), diluents, and testing time points dictated by intended hold time.
Insights
Microbial challenge studies assess drug product contamination risk and preservative effectiveness to ensure patient safety. These studies inform decisions on hold times, formulation, and storage conditions for biological products.
Area of Science:
- Pharmaceutical Science
- Microbiology
- Regulatory Science
Background:
- Evolving pharmaceutical industry necessitates updated regulatory requirements for biological products.
- Establishing in-use hold times is critical for patient safety in clinical settings.
- Microbial challenge studies, adapted from USP Chapter <51>, are non-compendial assessments of microbial growth potential.
Purpose of the Study:
- To evaluate the microbial growth potential of pharmaceutical products.
- To determine safe in-use hold times for drug products.
- To assess preservative effectiveness and optimize storage conditions.
Main Methods:
- Simulating inadvertent contamination by spiking products with low levels of microorganisms.
- Evaluating microbial growth potential under various storage conditions.
- Considering drug product formulation, target organisms, diluents, and testing time points.
Main Results:
- Data informs decisions on product formulation, storage conditions, and acceptable hold times.
- Identifies if microorganisms can grow in the product during the holding period.
- Provides insights into the effectiveness of preservatives and preservative ingredients.
Conclusions:
- Microbial challenge studies are essential for ensuring the safety and stability of biological products.
- Reevaluation of hold times, formulation, or storage is necessary if microbial growth occurs.
- Careful study design, considering multiple factors, is crucial for accurate results.
